Literature DB >> 10387039

Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment.

J A Javitch1, J A Ballesteros, J Chen, V Chiappa, M M Simpson.   

Abstract

The binding-site of the dopamine D2 receptor, like that of other homologous G protein-coupled receptors, is contained within a water-accessible crevice formed among its seven membrane-spanning segments. Using the substituted cysteine accessibility method (SCAM), we previously mapped the residues in the third, fifth, sixth, and seventh membrane-spanning segments that contribute to the surface of this binding-site crevice. We have now mutated to cysteine, one at a time, 22 consecutive residues in the second membrane-spanning segment (M2) and expressed the mutant receptors in HEK 293 cells. Eleven of these mutants reacted with charged, hydrophilic, lipophobic, sulfhydryl-specific reagents, added extracellularly, and 9 of these 11 were protected from reaction by a reversible dopamine antagonist, sulpiride. We infer that the side chains of the residues at the 11 reactive loci (D80, L81, V83, V87, P89, W90, V91, V92, L94, E95, V96) are on the water-accessible surface of the binding-site crevice and that 9 of these are occluded by bound antagonist. The pattern of accessibility suggests an alpha-helical conformation. A broadening of the angle of accessibility near the binding site is consistent with the presence of a kink at Pro89. On the basis of the enhanced rates of reaction of positively charged sulfhydryl reagents, we infer the presence of an electrostatic microdomain composed of three acidic residues in M2 and the adjacent M3 that could attract and orient cationic ligands. Furthermore, based on the enhanced reactivity of the hydrophobic cation-containing reagent, we infer the presence of an aromatic microdomain formed between M2, M3, and M7.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10387039     DOI: 10.1021/bi9905314

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

Review 1.  G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin.

Authors:  J Ballesteros; K Palczewski
Journal:  Curr Opin Drug Discov Devel       Date:  2001-09

2.  Residues accessible in the binding-site crevice of transmembrane helix 6 of the CB2 cannabinoid receptor.

Authors:  Ntsang M Nebane; Dow P Hurst; Carl A Carrasquer; Zhuanhong Qiao; Patricia H Reggio; Zhao-Hui Song
Journal:  Biochemistry       Date:  2008-12-30       Impact factor: 3.162

3.  The seventh transmembrane domains of the delta and kappa opioid receptors have different accessibility patterns and interhelical interactions.

Authors:  Wei Xu; Mercedes Campillo; Leonardo Pardo; J Kim de Riel; Lee-Yuan Liu-Chen
Journal:  Biochemistry       Date:  2005-12-13       Impact factor: 3.162

4.  Modeling and protein engineering studies of active and inactive states of human dopamine D2 receptor (D2R) and investigation of drug/receptor interactions.

Authors:  Ramin Ekhteiari Salmas; Mine Yurtsever; Matthias Stein; Serdar Durdagi
Journal:  Mol Divers       Date:  2015-02-05       Impact factor: 2.943

5.  Induced effects of sodium ions on dopaminergic G-protein coupled receptors.

Authors:  Jana Selent; Ferran Sanz; Manuel Pastor; Gianni De Fabritiis
Journal:  PLoS Comput Biol       Date:  2010-08-12       Impact factor: 4.475

6.  The second transmembrane domain of the human type 1 angiotensin II receptor participates in the formation of the ligand binding pocket and undergoes integral pivoting movement during the process of receptor activation.

Authors:  Ivana Domazet; Brian J Holleran; Stéphane S Martin; Pierre Lavigne; Richard Leduc; Emanuel Escher; Gaétan Guillemette
Journal:  J Biol Chem       Date:  2009-03-09       Impact factor: 5.157

7.  Shift in purine/pyrimidine base recognition upon exchanging extracellular domains in P2Y 1/6 chimeric receptors.

Authors:  Carsten Hoffmann; Kelly Soltysiak; Patrick L West; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2004-11-15       Impact factor: 5.858

8.  Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 98(3.36) of the human histamine H₄ receptor.

Authors:  S Nijmeijer; H Engelhardt; S Schultes; A C van de Stolpe; V Lusink; C de Graaf; M Wijtmans; E E J Haaksma; I J P de Esch; K Stachurski; H F Vischer; R Leurs
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

9.  The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice.

Authors:  Lei Shi; Jonathan A Javitch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-02       Impact factor: 11.205

10.  New vistas in GPCR 3D structure prediction.

Authors:  Anwar Rayan
Journal:  J Mol Model       Date:  2009-06-24       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.